Title

Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW
Comparison Expectant With Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Study Participants

    200
Compared the interest of one week expectancy vs immediate medical treatment in the taking care of the evacuation of the no evolutionary pregnancies before 13 GW.
Randomized control trial comparing one week expectancy vs immediate medical treatment (mifepristone 200mg and misoprostol 400ug) in the taking care of the evacuation of the no evolutionary pregnancies before 13 GW.
Study Started
Apr 30
2003
Primary Completion
Sep 30
2006
Study Completion
Sep 30
2006
Last Update
May 02
2011
Estimate

Drug MIFEPRISTONE 200 mg and misoprostol 400 µg

MIFEPRISTONE 200 mg and misoprostol 400 µg

1 Experimental

MIFEPRISTONE 200 mg and misoprostol 400 µg

Criteria

Inclusion Criteria:

Agreed women aged over 18 yrs old

Non evolutive pregnancy before 13GW :

Non evolutive pregnancy with no fetal cardiac activity
Non evolutive pregnancy with embryonic structures
Trophoblastic material in uterine cavity P bhCG < 10UI/L

Exclusion criteria:

Age < 18 years
pregnancy evolutionary
not evolutionary pregnancy after 13 weeks of amenorrhoea characterized by the presence of an scan image intra-uterine ANECHOGENE furthermore of 50mm of diameter
amenorrhoea of more than 13 weeks
pregnancy twin
pregnancy molar
pregnancy extra-uterine
Extra-uterine pregnancy
one or many contraindications in the mifepristone:
Allergy known about the MIFEPRISTONE
Incapacity suprarenal
corticosteroid therapy in the long price
confusions of the haemostasis (thrombopenia < in 100000 / mm3)
anaemia (rate Hg < in 9 g / dl)
contraindication in the misoprostol
allergy known about PROSTAGLANDINES
BEANCE cervical
No Results Posted